1. Home
  2. BOLD vs GLBS Comparison

BOLD vs GLBS Comparison

Compare BOLD & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • GLBS
  • Stock Information
  • Founded
  • BOLD 2018
  • GLBS 2006
  • Country
  • BOLD United States
  • GLBS Greece
  • Employees
  • BOLD N/A
  • GLBS N/A
  • Industry
  • BOLD
  • GLBS Marine Transportation
  • Sector
  • BOLD
  • GLBS Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • GLBS Nasdaq
  • Market Cap
  • BOLD 24.4M
  • GLBS 21.4M
  • IPO Year
  • BOLD 2024
  • GLBS 2007
  • Fundamental
  • Price
  • BOLD $1.15
  • GLBS $1.07
  • Analyst Decision
  • BOLD Buy
  • GLBS Strong Buy
  • Analyst Count
  • BOLD 4
  • GLBS 1
  • Target Price
  • BOLD $4.00
  • GLBS $3.00
  • AVG Volume (30 Days)
  • BOLD 77.7K
  • GLBS 37.0K
  • Earning Date
  • BOLD 11-06-2025
  • GLBS 09-12-2025
  • Dividend Yield
  • BOLD N/A
  • GLBS N/A
  • EPS Growth
  • BOLD N/A
  • GLBS N/A
  • EPS
  • BOLD N/A
  • GLBS N/A
  • Revenue
  • BOLD N/A
  • GLBS $35,776,000.00
  • Revenue This Year
  • BOLD N/A
  • GLBS $5.01
  • Revenue Next Year
  • BOLD N/A
  • GLBS $27.86
  • P/E Ratio
  • BOLD N/A
  • GLBS N/A
  • Revenue Growth
  • BOLD N/A
  • GLBS 17.92
  • 52 Week Low
  • BOLD $1.00
  • GLBS $0.99
  • 52 Week High
  • BOLD $4.72
  • GLBS $2.21
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 49.88
  • GLBS 53.48
  • Support Level
  • BOLD $1.13
  • GLBS $1.01
  • Resistance Level
  • BOLD $1.16
  • GLBS $1.09
  • Average True Range (ATR)
  • BOLD 0.04
  • GLBS 0.04
  • MACD
  • BOLD 0.00
  • GLBS 0.01
  • Stochastic Oscillator
  • BOLD 55.56
  • GLBS 72.22

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: